Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
NCT Number: NCT00648687
Newborns infants equal or less than 1500 grams and/or equal and less than 32 weeks will have ophthalmologic examination for ROP at 6 weeks old. They will be randomized blindly to receive 2 ml of 12.5% dextrose in water (D12.5W) orally five minute before examination (intervention group) or nothing (control). NIPS scale will be applied two minutes before examination and two minutes after examination.
Looking for future studies?
Notify Me5 week–6 month
All sexes
Interventional
Not applicable
Porto Alegre, Rio Grande do Sul, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Newborns will suck 2 ml of D12.5W 5 minutes before eye exam for ROP
Time frame: 2 minutes after the exam
National Bioethics Commission of Brazil
Other
Evaluation of the Pain Response During Examination for Retinopathy of Prematurity in Very Low Birth Weight Infants
Acronym: ROP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07016984
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Sariyer, İ̇stanbul, Turkey (Türkiye)
View Trial DetailsNCT00895869
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Edinburgh, United Kingdom
View Trial DetailsNCT03650621
Acupuncture, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Sydney, New South Wales, Australia
View Trial DetailsNCT03824782
Apnea, Arrhythmias, Cardiac
Toronto, Ontario, Canada
View Trial Details